Dermatology Research Review, Issue 35

In this issue:

Risankizumab vs. ustekinumab in plaque psoriasis
Association of PD-L1 expression in BCC with number of treatment modalities
Oncogene mutations in cetuximabtreated advanced cutaneous SCC
Major CV event risk with biologicals for psoriasis
Genital melanosis in men and women
Avascular necrosis risk increased in psoriasis
Silk textile with antimicrobial for acne vulgaris on the back
Bacterial biofilm in hidradenitis suppurativa lesions
Continuous vs. interrupted ixekizumab for psoriasis
Clinical markers of vitiligo activity

Please login below to download this issue (PDF)

Subscribe